AI is accelerating the pace and precision of early-stage biotech, from molecule screening to patient targeting. At LongeVC, we continue to back the founders translating next-gen tools into clinical and commercial outcomes.
LongeVC senior associate Artemy Shumskiy will join the judging panel for the 2025 Nebius AI Discovery Award. The accolade highlights breakthrough work in AI-powered drug discovery, genomics, and healthtech, and is a part of the HLTH Europe event, held on June 16-19 at the RAI Convention Centre in Amsterdam.
Finalists will be invited to Amsterdam to pitch their projects live on June 18. If you plan to be in town, contact Artemy directly or email us at hq@longevc.com.
Learn more about the award and the event at nebius.com.
LongeVC senior associate Artemy Shumskiy will join the judging panel for the 2025 Nebius AI Discovery Award. The accolade highlights breakthrough work in AI-powered drug discovery, genomics, and healthtech, and is a part of the HLTH Europe event, held on June 16-19 at the RAI Convention Centre in Amsterdam.
Finalists will be invited to Amsterdam to pitch their projects live on June 18. If you plan to be in town, contact Artemy directly or email us at hq@longevc.com.
Learn more about the award and the event at nebius.com.